News

Calibration of schizophrenia treatment is a delicate balancing act

Publish date: February 23, 2016

 

EXPERT ANALYSIS AT THE NPA PSYCHOPHARMACOLOGY UPDATE

References

Dr. Weiden reported having numerous financial ties to the pharmaceutical industry, as well as being a stockholder of Delpor.

dbrunk@frontlinemedcom.com

Pages

Recommended Reading

Cariprazine for schizophrenia and bipolar I disorder
MDedge Psychiatry
Cariprazine for schizophrenia and bipolar I disorder
MDedge Psychiatry
Stop blaming ‘demons’ for bizarre delusions or behavior!
MDedge Psychiatry
Delusions, hypersexuality, and a steep cognitive decline
MDedge Psychiatry
From paranoid fear to completed homicide
MDedge Psychiatry
Component of C4 gene implicated in schizophrenia risk
MDedge Psychiatry
Childhood exposure to domestic violence tied to violent behavior in adult schizophrenia
MDedge Psychiatry
We are not ‘psychiatrists’; 'The beauty of the asylum’; Challenges with false-positive urine drug screens
MDedge Psychiatry
Unresponsive and mute after he smoked ‘Spice’
MDedge Psychiatry
Reducing morbidity and mortality from common medical conditions in schizophrenia
MDedge Psychiatry